Tenoxicam

Producer:Nantong Jinghua Pharmaceutical Co., Ltd.by Share Ltd, the company currently has 248 specifications of drug approval number, the total assets of the company amounted to 250 million yuan, covers an area of 140000 square meters. 

The company's API has obtained 9 International certifications, among which fluorouracil has passed the FDA certification of the United States, and four products such as phenobarbital and butazone have obtained the cos certification of Europe. Among the bulk drugs, fluorouracil obtained the European cos Certificate in 2000, butazone obtained the European cos Certificate in October 2006, and phenobarbital and promethasone have also applied for cos. The annual production capacity of the company is: 1000 tons of APIs and intermediates, 2000 tons of traditional Chinese medicine extraction, 1000 tons of granules, 1.5 billion tablets, 120 million injections and 80 million capsules. The company organizes production in strict accordance with GMP requirements, and the drug quality is in strict accordance with the standards of Chinese Pharmacopoeia, European Pharmacopoeia, British Pharmacopoeia and American Pharmacopoeia.